← Leaderboards
Wen L Seng
Phylonix Pharmaceuticals, Inc.
$5,142,092
Attributed
$5,243,704
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $685.3K · FY2006–12$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,243,704 · 12
By mechanism
R44$4,006,994 · 5
R43$1,236,710 · 7
Top collaborators
- Musodiq O Bello1 shared
Most similar at Phylonix Pharmaceuticals, Inc.
Same institution · by research overlap
- Catherine E Willett$2,861,955
- Maryann L Haldi$2,524,006
- Demian Park$957,438
- George N Serbedzija$822,432
- Musodiq O Bello$101,612
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishTechnology /Technique DevelopmentDrug Screening /EvaluationAngiogenesisAngiogenesis InhibitorsAnimal ModelPharmaceutical PreparationsStainsStaining MethodClinical TrialsBaseEnzymesEmbryo /Fetus CultureAlternatives To Animals In ResearchLibrariesDiabetic RetinopathyEmbryo /Fetus Drug Adverse EffectGovernmentInfectionBlindnessBlood VesselsAdultEvaluationAntibodies
Grant awards (21)
Device for Automating Zebrafish Processing$413,650
R44 · FY2012 · GM · contact PI
In Vivo Ocular Angiogenesis Assay$408,176
R44 · FY2009 · EY · contact PI
High-Content Analysis Tools for Developmental Toxicity Screens in Zebrafish$203,224
R43 · FY2009 · ES · contact PI
In Vivo Ocular Angiogenesis Assay$49,280
R44 · FY2009 · EY · contact PI
A New Model for Eye Disease$24,640
R44 · FY2009 · EY · contact PI
In Vivo Ocular Angiogenesis Assay$334,807
R44 · FY2008 · EY · contact PI
New Whole Animal ELISA for Angiogenic Drug Screening$135,227
R43 · FY2008 · HL · contact PI
In Vivo Ocular Angiogenesis Assay$202,041
R44 · FY2007 · EY · contact PI
A New Model for Eye Disease$158,186
R44 · FY2007 · EY · contact PI
A New Model for Eye Disease$438,978
R44 · FY2006 · EY · contact PI
Zebrafish Wound Healing Model for Drug Screening$166,562
R43 · FY2006 · DK · contact PI
Whole Animal Assay for Angiogenesis Inhibition$176,617
R44 · FY2004 · CA
Hypoxia Induced Ocular Neovascularization Model$172,701
R43 · FY2004 · EY
Whole Animal Microplate Assay for Angiogenesis$149,464
R44 · FY2004 · CA
Whole Animal Assay for Angiogenesis Inhibition$344,139
R44 · FY2003 · CA
Whole Animal Microplate Assay for Angiogenesis$298,095
R44 · FY2003 · CA
Whole Animal Microplate Assay for Angiogenesis$577,843
R44 · FY2002 · CA
Whole Animal Assay for Angiogenesis Inhibition$431,078
R44 · FY2002 · CA
Whole Animal ELISA for Liver Toxicity$185,796
R43 · FY2002 · CA
Whole Animal Microplate Assay for Toxicity Screening$188,059
R43 · FY2001 · ES
Whole Animal Angiogenesis ELISA for Drug Screening$185,141
R43 · FY2001 · CA